Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sucampo Pharmaceuticals Inc (NASDAQ:SCMP)

11.41
Delayed Data
As of Jul 22
 -0.20 / -1.72%
Today’s Change
9.59
Today|||52-Week Range
29.67
-34.01%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues81.5M89.6M115.5M153.2M
 
 
 
 
 
Cost of Goods Sold1.5M10.9M15.2M26.2M
 
 
 
 
 
Depreciation And Amortization1.5M1.5M1.1M10.6M
 
 
 
 
 
 
Operating ExpensesGross Income78.5M77.2M99.2M116.4M
 
 
 
 
 
General Expenses70.1M68.0M66.3M72.0M
 
 
 
 
 
Research And Development21.3M21.5M20.6M33.6M
 
 
 
 
 
Total Operating Expenses73.2M80.4M82.6M108.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income8.3M9.2M32.9M44.5M
 
 
 
 
 
Extraordinary Charge0.000.00-5.6M0.00
 
 
Interest Expense On Debt2.3M1.9M1.5M6.9M
 
 
 
 
 
Other Expenses1.6M2.9M1.3M5.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income7.8M10.3M27.1M43.7M
 
 
 
 
 
Income Taxes-2.9M-3.9M-14.0M-10.3M
 
 
 
 
 
Net Income4.8M6.4M13.1M33.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.7M41.7M43.7M44.2M
 
 
 
 
 
Shares To Calculate EPS Diluted41.8M42.5M44.5M45.7M
 
 
 
 
 
 
Earnings Per ShareEPS$0.12$0.15$0.29$0.73
 
 
 
 
 
EPS Diluted$0.12$0.15$0.29$0.73